Free Trial
→ “Buffett Indicator” Predicts 62% Stock Market Crash (From Behind the Markets) (Ad) Free YS Stock Alerts

YS Biopharma (YS) SEC Filings & 10K Form

$0.74
-0.03 (-3.87%)
(As of 09/19/2024 ET)
Compare

Recent YS Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
09/10/2024
3:00 PM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K/A
09/10/2024
7:15 AM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
7:10 AM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
7:40 AM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:28 AM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/31/2024
6:15 AM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form NT 20-F
07/05/2024
6:15 AM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
6:30 AM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
6:01 AM		YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
6:45 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
3:30 PM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2024
3:16 PM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/08/2024
7:32 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
04/29/2024
7:15 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:03 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:15 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:20 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2024
7:10 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
7:06 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
7:15 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:17 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
7:25 PM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
3:14 PM		YS Biopharma (Subject)
YS Biopharma Co., Ltd. (Subject)
YS Biopharma Co., Ltd. (Subject)
Zhang /MD Yi (Filed by)
Form SC 13G/A
02/14/2024
10:23 AM		Wong Fung Ching (Filed by)
YS Biopharma (Subject)
YS Biopharma Co., Ltd. (Subject)
YS Biopharma Co., Ltd. (Subject)
Form SC 13D
02/14/2024
6:59 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:01 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:05 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2024
6:10 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/25/2024
11:15 PM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form EFFECT
01/26/2024
5:03 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2024
3:18 PM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form POS AM
01/22/2024
4:10 PM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
6:10 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
11:43 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2023
5:37 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2023
7:45 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2023
7:46 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
10/26/2023
7:45 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2023
8:10 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2023
8:13 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
09/25/2023
5:12 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
Our #1 Ticker for the Rare "Retirement Window" (Ad)

We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.

Click here for our #1 "Retirement Window" Stock >>>
09/25/2023
5:07 AM		YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:

This page (NASDAQ:YS) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners
Sell NVDA Now?
Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...
Chaikin Analytics | Sponsored
Unlock the Secret to Easy Wins with Iron Condors
Discover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...
Netpicks | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
The death of Nvidia?
Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....
Porter & Company | Sponsored
Forget ChatGPT: Follow the AI Retirement Playbook
Everyone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...
Brownstone Research | Sponsored
Dump Nvidia, Apple, and Tesla Before It’s Too Late
The financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...
InvestorPlace | Sponsored
This Crypto Is Set to Explode in September
With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...
Crypto 101 Media | Sponsored